Top Ten Things to Do at ODAC Miami 2018
340534053405Top 1010.) Download the app for maps, schedule, and to sign up for your complimentary JDD!  Bring your own smartphone, tablet or device to General Session to view/save PPT slides, take notes, participate in Q&A, take surveys, and more. To download the ODAC 2018 onsite app:  -  Navigate to your device’s preferred app store (Apple App Store or Google Play Store). -   Search for “ODAC 2 …
Top 10
GW Resident Segment – January 2018 Edition with Dr. Hsu
340034003400In this throwback edition of the JDD Podcast "Ask the Investigator," host Adam Friedman speaks with Dr. Sylvia Hsu, Professor and Chair of Dermatology at the Lewis Katz School of Medicine at Temple University on her study published in the August 2008 edition of the JDD entitled, "A Case Series of 48 Patients Treated with Thalidomide." Get a taste of rich dermatology history with the evolution of t …
January JDD Highlights
339033903390A Multi-Center, Open-Label, Prospective Study of Cannula Injection of Small-Particle Hyaluronic Acid Plus Lidocaine (SPHAL) for Lip Augmentation assesses the safety and effectiveness associated with the use of a blunt-tipped microcannula for lip augmentation and correction of perioral rhytids using a small-particle, hyaluronic acid gel plus lidocaine   Educating men about available aes …
GW Resident Segment – December Edition with Dr. Shapiro
333933393339superpotentQuestion 1 In your JDD podcast interview, you mentioned that about 50-60% of your patients with LPP respond to naltrexone. Have you seen any similarities between these responders that could help dermatologists identify which patients would be good candidates for naltrexone as an adjunctive therapy? Answer "No I have not seen any similarities. The response is unpredictable."   Quest …
superpotent
JDD December Issue Highlights
332133213321JDD logoHuman fibroblasts are a versatile source of optimal growth factors that provide approaches to repair skin in Upregulation of Extracellular Matrix Genes Corroborates Clinical Efficacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvenation   By working from a CD8+ T cell line, it should be possible to identify and patent products capable of treating infectious diseases, antigen- …
JDD logo